The Clinical Relevance of Serum NDKA, NMDA, PARK7, and UFDP Levels with Phlegm-Heat Syndrome and Treatment Efficacy Evaluation of Traditional Chinese Medicine in Acute Ischemic Stroke

Figure 3

Dynamic changes of serum biological markers and scale scores of therapeutic efficacy in patients within 3 days of onset and 7 and 14 days after onset of stroke. (a) Serum NDKA, NMDA, PARK7, and UFDP levels in patients within 3 days of onset and 7 and 14 days after onset of stroke. (14 days versus 7 days and 3 days). (b) NIHSS scores within the onset of 3 days and 7 and 14 days after onset. (3 days versus 7 days), (7 days versus 14 days). (c) Phlegm-heat syndrome scores within the onset of 3 days and 7 and 14 days after onset. (3 days versus 7 days), (7 days versus 14 days).

(a)

(b)

(c)